In addition to representing known oncogenic mutations, mosaic variants in KRAS have been described in multiple conditions, including epidermal nevus, nevus sebaceous and Schimmelpenning syndrome, encephalocraniocutaneous lipomatosis, and phacomatosis pigmentokeratotica [21]. This evidence concerns the gene KRAS and nevus, epidermal.